Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Simian immunodeficiency virus | 89 | 2023 | 846 | 17.400 |
Why?
|
AIDS Vaccines | 95 | 2023 | 938 | 16.420 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 70 | 2023 | 570 | 16.140 |
Why?
|
Antibodies, Neutralizing | 112 | 2024 | 1978 | 14.260 |
Why?
|
Adenoviridae | 65 | 2021 | 1099 | 12.660 |
Why?
|
Macaca mulatta | 145 | 2024 | 2375 | 12.520 |
Why?
|
Viral Vaccines | 46 | 2023 | 636 | 11.850 |
Why?
|
HIV-1 | 123 | 2024 | 6939 | 10.850 |
Why?
|
Antibodies, Viral | 103 | 2024 | 3176 | 10.450 |
Why?
|
Genetic Vectors | 74 | 2023 | 3420 | 7.450 |
Why?
|
HIV Antibodies | 54 | 2024 | 1322 | 7.340 |
Why?
|
SAIDS Vaccines | 31 | 2020 | 166 | 7.150 |
Why?
|
Adenoviruses, Human | 24 | 2018 | 257 | 6.720 |
Why?
|
Vaccines, DNA | 42 | 2020 | 305 | 5.730 |
Why?
|
Immunity, Cellular | 39 | 2022 | 1607 | 5.470 |
Why?
|
Vaccines, Synthetic | 41 | 2023 | 634 | 5.110 |
Why?
|
Immunization, Secondary | 18 | 2023 | 340 | 4.650 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 24 | 2020 | 370 | 4.500 |
Why?
|
HIV Infections | 99 | 2024 | 16718 | 4.420 |
Why?
|
Immunity, Humoral | 27 | 2022 | 598 | 4.230 |
Why?
|
CD4-Positive T-Lymphocytes | 44 | 2023 | 4386 | 3.560 |
Why?
|
CD8-Positive T-Lymphocytes | 49 | 2023 | 4479 | 3.540 |
Why?
|
Immunity, Mucosal | 14 | 2023 | 490 | 3.250 |
Why?
|
Vaccination | 62 | 2024 | 3278 | 2.980 |
Why?
|
Capsid Proteins | 14 | 2021 | 479 | 2.900 |
Why?
|
Viral Load | 43 | 2023 | 3299 | 2.810 |
Why?
|
Animals | 269 | 2024 | 168757 | 2.650 |
Why?
|
Gene Products, env | 13 | 2020 | 263 | 2.610 |
Why?
|
Anti-Retroviral Agents | 18 | 2023 | 1715 | 2.610 |
Why?
|
Lymphocytic choriomeningitis virus | 7 | 2021 | 168 | 2.410 |
Why?
|
Antigens, Viral | 21 | 2023 | 1035 | 2.400 |
Why?
|
Virus Replication | 27 | 2023 | 2534 | 2.300 |
Why?
|
Cross Reactions | 13 | 2022 | 841 | 2.270 |
Why?
|
Immunization, Passive | 12 | 2022 | 623 | 2.250 |
Why?
|
Adenovirus Infections, Human | 6 | 2014 | 71 | 2.160 |
Why?
|
Immunologic Memory | 19 | 2021 | 1348 | 2.090 |
Why?
|
Gene Products, gag | 24 | 2020 | 337 | 2.030 |
Why?
|
Vaccines | 14 | 2023 | 822 | 2.020 |
Why?
|
Vaccinia virus | 14 | 2024 | 349 | 1.950 |
Why?
|
T-Lymphocytes | 39 | 2022 | 10180 | 1.950 |
Why?
|
Adenoviridae Infections | 7 | 2021 | 96 | 1.870 |
Why?
|
Toll-Like Receptor 7 | 6 | 2022 | 172 | 1.850 |
Why?
|
Antibody Formation | 14 | 2024 | 1402 | 1.820 |
Why?
|
Drug Carriers | 11 | 2018 | 693 | 1.820 |
Why?
|
Epitopes | 24 | 2023 | 2571 | 1.790 |
Why?
|
Adjuvants, Immunologic | 15 | 2024 | 1000 | 1.710 |
Why?
|
Epitopes, T-Lymphocyte | 19 | 2021 | 880 | 1.700 |
Why?
|
Immunoglobulin G | 26 | 2024 | 4560 | 1.650 |
Why?
|
Neutralization Tests | 22 | 2022 | 758 | 1.510 |
Why?
|
T-Lymphocytes, Cytotoxic | 27 | 2021 | 1821 | 1.500 |
Why?
|
Immunity, Innate | 17 | 2023 | 2958 | 1.420 |
Why?
|
Macaca | 10 | 2023 | 440 | 1.420 |
Why?
|
Pandemics | 17 | 2023 | 8388 | 1.380 |
Why?
|
HIV Envelope Protein gp120 | 11 | 2021 | 952 | 1.360 |
Why?
|
Viremia | 11 | 2022 | 736 | 1.310 |
Why?
|
Smallpox Vaccine | 3 | 2024 | 80 | 1.300 |
Why?
|
Disease Models, Animal | 28 | 2022 | 18029 | 1.290 |
Why?
|
Coronavirus Infections | 9 | 2020 | 3133 | 1.260 |
Why?
|
Injections, Intramuscular | 16 | 2023 | 552 | 1.250 |
Why?
|
Mice, Inbred BALB C | 29 | 2022 | 6386 | 1.250 |
Why?
|
Pneumonia, Viral | 9 | 2020 | 3240 | 1.240 |
Why?
|
HIV Seropositivity | 4 | 2023 | 971 | 1.220 |
Why?
|
Antibodies, Monoclonal | 20 | 2023 | 9274 | 1.210 |
Why?
|
Immunization | 18 | 2024 | 1256 | 1.130 |
Why?
|
HIV | 11 | 2022 | 1604 | 1.120 |
Why?
|
Cytokines | 19 | 2023 | 7322 | 1.120 |
Why?
|
Killer Cells, Natural | 8 | 2023 | 2133 | 1.110 |
Why?
|
Lymphocyte Depletion | 4 | 2018 | 608 | 1.110 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 2018 | 2232 | 1.050 |
Why?
|
DNA, Viral | 13 | 2021 | 2225 | 1.050 |
Why?
|
Humans | 248 | 2024 | 744343 | 1.050 |
Why?
|
Immunity, Maternally-Acquired | 4 | 2020 | 118 | 1.050 |
Why?
|
Mice | 86 | 2023 | 81183 | 1.040 |
Why?
|
Viral Envelope Proteins | 11 | 2023 | 635 | 1.030 |
Why?
|
RNA, Viral | 14 | 2021 | 2902 | 1.020 |
Why?
|
Vaccines, Inactivated | 4 | 2020 | 184 | 1.010 |
Why?
|
Adoptive Transfer | 10 | 2020 | 844 | 0.980 |
Why?
|
Vaccines, Attenuated | 4 | 2020 | 342 | 0.950 |
Why?
|
Thrombosis | 3 | 2023 | 2968 | 0.940 |
Why?
|
Mice, Inbred C57BL | 38 | 2021 | 21827 | 0.940 |
Why?
|
Immunoglobulin A | 6 | 2023 | 992 | 0.930 |
Why?
|
Lymphocytic Choriomeningitis | 4 | 2021 | 132 | 0.920 |
Why?
|
Monkeypox virus | 1 | 2023 | 48 | 0.920 |
Why?
|
Plasmids | 19 | 2011 | 2307 | 0.880 |
Why?
|
Tuberculosis Vaccines | 3 | 2020 | 50 | 0.880 |
Why?
|
Dengue | 4 | 2023 | 256 | 0.860 |
Why?
|
Adenoviruses, Simian | 2 | 2021 | 14 | 0.860 |
Why?
|
Female | 115 | 2024 | 380194 | 0.810 |
Why?
|
Immune Evasion | 3 | 2023 | 360 | 0.810 |
Why?
|
Mucous Membrane | 5 | 2019 | 673 | 0.810 |
Why?
|
Dengue Vaccines | 1 | 2021 | 14 | 0.800 |
Why?
|
Listeria monocytogenes | 2 | 2014 | 250 | 0.800 |
Why?
|
Nucleosides | 1 | 2021 | 138 | 0.780 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 6 | 2016 | 222 | 0.780 |
Why?
|
Capsid | 2 | 2021 | 436 | 0.780 |
Why?
|
Antiviral Agents | 4 | 2022 | 2987 | 0.750 |
Why?
|
Cancer Vaccines | 5 | 2021 | 1023 | 0.730 |
Why?
|
alpha-Defensins | 1 | 2019 | 28 | 0.720 |
Why?
|
Interleukin-2 | 12 | 2014 | 1904 | 0.720 |
Why?
|
Guinea Pigs | 8 | 2019 | 1386 | 0.710 |
Why?
|
Cricetinae | 6 | 2022 | 2472 | 0.690 |
Why?
|
Integrin alpha4 | 1 | 2019 | 92 | 0.690 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2019 | 107 | 0.690 |
Why?
|
Integrin beta Chains | 1 | 2019 | 121 | 0.680 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2019 | 442 | 0.660 |
Why?
|
Double-Blind Method | 19 | 2022 | 12026 | 0.650 |
Why?
|
Immunodominant Epitopes | 6 | 2006 | 267 | 0.650 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2018 | 99 | 0.640 |
Why?
|
Adaptive Immunity | 7 | 2023 | 713 | 0.630 |
Why?
|
Transduction, Genetic | 3 | 2018 | 913 | 0.630 |
Why?
|
Depsipeptides | 1 | 2018 | 94 | 0.630 |
Why?
|
Male | 85 | 2023 | 350118 | 0.630 |
Why?
|
Fetal Blood | 2 | 2021 | 1318 | 0.620 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 15 | 2017 | 3870 | 0.600 |
Why?
|
Bronchoalveolar Lavage Fluid | 5 | 2021 | 768 | 0.590 |
Why?
|
Intestinal Mucosa | 6 | 2014 | 3036 | 0.590 |
Why?
|
Immunoglobulin Fc Fragments | 6 | 2018 | 279 | 0.580 |
Why?
|
Virulence Factors | 1 | 2020 | 509 | 0.580 |
Why?
|
Lymphocyte Activation | 11 | 2021 | 5524 | 0.580 |
Why?
|
Primates | 8 | 2022 | 545 | 0.570 |
Why?
|
Foreskin | 2 | 2014 | 31 | 0.570 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.570 |
Why?
|
Placenta | 2 | 2023 | 1698 | 0.560 |
Why?
|
Lymphoid Tissue | 3 | 2022 | 455 | 0.540 |
Why?
|
HLA-A2 Antigen | 8 | 2011 | 213 | 0.530 |
Why?
|
Nanoparticles | 3 | 2023 | 1905 | 0.530 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1179 | 0.530 |
Why?
|
Gene Products, pol | 5 | 2020 | 47 | 0.520 |
Why?
|
Canarypox virus | 2 | 2013 | 10 | 0.510 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 561 | 0.510 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 1477 | 0.510 |
Why?
|
Arenaviridae Infections | 1 | 2015 | 51 | 0.510 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 2 | 2016 | 153 | 0.500 |
Why?
|
Clinical Trials as Topic | 13 | 2020 | 7913 | 0.500 |
Why?
|
Dendritic Cells | 6 | 2019 | 2725 | 0.500 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 2 | 2012 | 39 | 0.490 |
Why?
|
Inflammasomes | 2 | 2016 | 495 | 0.490 |
Why?
|
Mesocricetus | 4 | 2022 | 252 | 0.480 |
Why?
|
Cloning, Molecular | 3 | 2018 | 4320 | 0.470 |
Why?
|
Leukocytes, Mononuclear | 8 | 2024 | 1836 | 0.470 |
Why?
|
B-Lymphocytes | 7 | 2021 | 4665 | 0.470 |
Why?
|
Peptide Fragments | 8 | 2021 | 5097 | 0.470 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1200 | 0.460 |
Why?
|
Vaccines, Subunit | 4 | 2024 | 168 | 0.450 |
Why?
|
Serum | 1 | 2014 | 214 | 0.450 |
Why?
|
Listeriosis | 1 | 2014 | 149 | 0.450 |
Why?
|
Endosomes | 2 | 2024 | 520 | 0.440 |
Why?
|
Serotyping | 6 | 2012 | 338 | 0.440 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.440 |
Why?
|
Viral Hepatitis Vaccines | 1 | 2012 | 80 | 0.430 |
Why?
|
Immunization Schedule | 4 | 2020 | 221 | 0.430 |
Why?
|
Immunoglobulins | 3 | 2016 | 881 | 0.430 |
Why?
|
Lymph Nodes | 3 | 2021 | 3474 | 0.420 |
Why?
|
Immune System Diseases | 1 | 2015 | 262 | 0.420 |
Why?
|
HIV Antigens | 6 | 2016 | 347 | 0.420 |
Why?
|
Amino Acid Sequence | 21 | 2021 | 13815 | 0.410 |
Why?
|
Bacterial Vaccines | 1 | 2014 | 403 | 0.400 |
Why?
|
Cell Movement | 6 | 2021 | 5217 | 0.390 |
Why?
|
Antigen-Presenting Cells | 3 | 2008 | 973 | 0.390 |
Why?
|
Young Adult | 25 | 2023 | 56430 | 0.390 |
Why?
|
Molecular Sequence Data | 25 | 2014 | 18111 | 0.380 |
Why?
|
Immune System | 2 | 2014 | 805 | 0.380 |
Why?
|
Vitamin A Deficiency | 1 | 2011 | 101 | 0.380 |
Why?
|
Adult | 42 | 2023 | 214055 | 0.380 |
Why?
|
Chemokines | 4 | 2012 | 970 | 0.370 |
Why?
|
Fetus | 1 | 2018 | 1880 | 0.370 |
Why?
|
Peptides | 4 | 2021 | 4409 | 0.370 |
Why?
|
Germinal Center | 3 | 2017 | 377 | 0.360 |
Why?
|
Administration, Intranasal | 4 | 2023 | 446 | 0.360 |
Why?
|
Genome, Viral | 4 | 2019 | 667 | 0.360 |
Why?
|
Macaca fascicularis | 3 | 2021 | 915 | 0.350 |
Why?
|
Placebos | 5 | 2021 | 1676 | 0.350 |
Why?
|
Antibodies | 2 | 2016 | 2460 | 0.350 |
Why?
|
Caliciviridae | 2 | 2023 | 5 | 0.340 |
Why?
|
RNA Viruses | 2 | 2023 | 124 | 0.340 |
Why?
|
Rectum | 4 | 2016 | 904 | 0.340 |
Why?
|
Inflammation | 6 | 2022 | 10638 | 0.330 |
Why?
|
Virus Latency | 3 | 2022 | 358 | 0.330 |
Why?
|
RNA, Messenger | 7 | 2024 | 13033 | 0.320 |
Why?
|
Immunogenetics | 1 | 2008 | 67 | 0.320 |
Why?
|
Gastric Mucosa | 1 | 2011 | 599 | 0.320 |
Why?
|
Smallpox | 1 | 2008 | 45 | 0.320 |
Why?
|
Drug Design | 3 | 2018 | 1076 | 0.310 |
Why?
|
Influenza in Birds | 1 | 2008 | 75 | 0.310 |
Why?
|
Dengue Virus | 4 | 2023 | 204 | 0.310 |
Why?
|
Evolution, Molecular | 2 | 2015 | 1940 | 0.310 |
Why?
|
Viral Proteins | 6 | 2021 | 1900 | 0.310 |
Why?
|
CD4 Lymphocyte Count | 9 | 2022 | 2559 | 0.300 |
Why?
|
Seroepidemiologic Studies | 4 | 2014 | 401 | 0.300 |
Why?
|
Nasal Mucosa | 2 | 2020 | 373 | 0.300 |
Why?
|
Lentivirus | 2 | 2018 | 501 | 0.300 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.300 |
Why?
|
Vagina | 5 | 2019 | 825 | 0.290 |
Why?
|
Virulence | 3 | 2022 | 1333 | 0.290 |
Why?
|
Toll-Like Receptor 4 | 1 | 2010 | 565 | 0.290 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2023 | 2988 | 0.290 |
Why?
|
Interferon-gamma | 10 | 2018 | 3206 | 0.280 |
Why?
|
Lung | 9 | 2023 | 9856 | 0.280 |
Why?
|
Gene Expression | 4 | 2021 | 7799 | 0.280 |
Why?
|
Administration, Oral | 3 | 2021 | 3913 | 0.280 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2021 | 1366 | 0.270 |
Why?
|
Antigen Presentation | 5 | 2021 | 1284 | 0.270 |
Why?
|
Immunoassay | 2 | 2021 | 752 | 0.270 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2020 | 1320 | 0.270 |
Why?
|
Reassortant Viruses | 1 | 2005 | 37 | 0.270 |
Why?
|
Inhibitory Concentration 50 | 4 | 2020 | 459 | 0.260 |
Why?
|
Terminal Repeat Sequences | 1 | 2005 | 72 | 0.260 |
Why?
|
Receptors, IgG | 2 | 2020 | 582 | 0.260 |
Why?
|
Mice, Knockout | 7 | 2021 | 14557 | 0.260 |
Why?
|
Phylogeny | 6 | 2021 | 2803 | 0.260 |
Why?
|
Hepacivirus | 1 | 2012 | 1379 | 0.260 |
Why?
|
Genetic Variation | 7 | 2020 | 6544 | 0.250 |
Why?
|
Viral Nonstructural Proteins | 2 | 2019 | 241 | 0.250 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2005 | 140 | 0.250 |
Why?
|
Middle Aged | 32 | 2023 | 213383 | 0.250 |
Why?
|
Models, Animal | 4 | 2020 | 2171 | 0.250 |
Why?
|
Pregnancy | 7 | 2023 | 29144 | 0.250 |
Why?
|
Drug Delivery Systems | 2 | 2021 | 2219 | 0.250 |
Why?
|
Immunologic Factors | 2 | 2014 | 1580 | 0.250 |
Why?
|
Proviruses | 4 | 2023 | 318 | 0.250 |
Why?
|
Antibody Specificity | 4 | 2016 | 1095 | 0.250 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 972 | 0.250 |
Why?
|
Zeolites | 1 | 2024 | 8 | 0.250 |
Why?
|
Cytomegalovirus | 3 | 2018 | 732 | 0.250 |
Why?
|
Lactation | 2 | 2021 | 412 | 0.240 |
Why?
|
Genes, Regulator | 1 | 2005 | 378 | 0.240 |
Why?
|
T-Lymphocyte Subsets | 5 | 2018 | 1838 | 0.240 |
Why?
|
Bronchoalveolar Lavage | 2 | 2021 | 120 | 0.230 |
Why?
|
Dose-Response Relationship, Immunologic | 6 | 2021 | 370 | 0.230 |
Why?
|
Lymphocytes | 1 | 2011 | 2617 | 0.230 |
Why?
|
Caliciviridae Infections | 1 | 2023 | 29 | 0.230 |
Why?
|
Receptors, Fc | 4 | 2022 | 541 | 0.220 |
Why?
|
Colony-Stimulating Factors | 1 | 2003 | 221 | 0.220 |
Why?
|
Norovirus | 1 | 2023 | 35 | 0.220 |
Why?
|
Africa South of the Sahara | 3 | 2014 | 724 | 0.220 |
Why?
|
Vaccines, Combined | 1 | 2023 | 69 | 0.220 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 4 | 2017 | 307 | 0.220 |
Why?
|
Kinetics | 6 | 2021 | 6473 | 0.210 |
Why?
|
Viruses | 2 | 2017 | 374 | 0.210 |
Why?
|
Hepatitis C | 1 | 2012 | 1591 | 0.210 |
Why?
|
Protein Multimerization | 4 | 2018 | 970 | 0.210 |
Why?
|
Base Sequence | 13 | 2017 | 12797 | 0.210 |
Why?
|
Virus Activation | 2 | 2022 | 319 | 0.210 |
Why?
|
Protein Binding | 11 | 2021 | 9386 | 0.210 |
Why?
|
Monkey Diseases | 2 | 2017 | 77 | 0.210 |
Why?
|
Cystitis | 1 | 2002 | 93 | 0.210 |
Why?
|
Aluminum Hydroxide | 1 | 2022 | 58 | 0.210 |
Why?
|
Brazil | 2 | 2016 | 1270 | 0.210 |
Why?
|
Vero Cells | 2 | 2020 | 485 | 0.200 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2020 | 365 | 0.200 |
Why?
|
Caspase 1 | 1 | 2022 | 224 | 0.200 |
Why?
|
Time Factors | 10 | 2020 | 40075 | 0.200 |
Why?
|
Viral Interference | 1 | 2021 | 12 | 0.200 |
Why?
|
Immunoglobulin M | 3 | 2020 | 1537 | 0.200 |
Why?
|
BK Virus | 1 | 2002 | 129 | 0.200 |
Why?
|
Antigens, Neoplasm | 3 | 2021 | 1988 | 0.200 |
Why?
|
Recombinant Fusion Proteins | 9 | 2011 | 3772 | 0.190 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 178 | 0.190 |
Why?
|
Proteome | 2 | 2021 | 1799 | 0.190 |
Why?
|
Genetic Engineering | 2 | 2006 | 951 | 0.190 |
Why?
|
Herpesviridae | 1 | 2001 | 109 | 0.190 |
Why?
|
Nose | 2 | 2021 | 509 | 0.190 |
Why?
|
Communicable Diseases | 2 | 2023 | 880 | 0.190 |
Why?
|
Adolescent | 17 | 2022 | 85781 | 0.190 |
Why?
|
Toll-Like Receptors | 3 | 2024 | 592 | 0.190 |
Why?
|
Protective Agents | 1 | 2021 | 156 | 0.190 |
Why?
|
Receptors, CXCR3 | 1 | 2021 | 237 | 0.190 |
Why?
|
Sequence Alignment | 5 | 2017 | 2256 | 0.180 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 77 | 0.180 |
Why?
|
Protein Engineering | 2 | 2021 | 540 | 0.180 |
Why?
|
Ferritins | 1 | 2023 | 590 | 0.180 |
Why?
|
Interleukin-6 | 2 | 2021 | 3200 | 0.180 |
Why?
|
Epitope Mapping | 3 | 2020 | 311 | 0.180 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1270 | 0.180 |
Why?
|
Genes, env | 2 | 2010 | 95 | 0.180 |
Why?
|
Ferrets | 1 | 2020 | 194 | 0.180 |
Why?
|
High-Throughput Screening Assays | 2 | 2017 | 944 | 0.180 |
Why?
|
Enzyme-Linked Immunospot Assay | 3 | 2016 | 130 | 0.180 |
Why?
|
Drug Discovery | 2 | 2020 | 1058 | 0.170 |
Why?
|
Sequence Analysis | 1 | 2020 | 256 | 0.170 |
Why?
|
Primate Diseases | 2 | 2013 | 15 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 903 | 0.170 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2019 | 159 | 0.170 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2017 | 1369 | 0.170 |
Why?
|
Codon, Terminator | 1 | 2019 | 127 | 0.170 |
Why?
|
DNA Primers | 7 | 2007 | 2892 | 0.170 |
Why?
|
Single-Chain Antibodies | 1 | 2019 | 108 | 0.170 |
Why?
|
Virion | 1 | 2021 | 433 | 0.170 |
Why?
|
Factor X | 2 | 2009 | 64 | 0.160 |
Why?
|
Pteridines | 1 | 2018 | 45 | 0.160 |
Why?
|
HIV-2 | 1 | 2019 | 167 | 0.160 |
Why?
|
Squalene | 1 | 2018 | 32 | 0.160 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2002 | 657 | 0.160 |
Why?
|
Complement Activation | 1 | 2020 | 453 | 0.160 |
Why?
|
Neurons | 1 | 2018 | 9338 | 0.160 |
Why?
|
Polysorbates | 1 | 2018 | 41 | 0.160 |
Why?
|
Treatment Outcome | 15 | 2021 | 63114 | 0.160 |
Why?
|
Genes, gag | 3 | 2010 | 61 | 0.160 |
Why?
|
Homosexuality, Male | 2 | 2023 | 1240 | 0.160 |
Why?
|
Cell Line | 12 | 2023 | 15997 | 0.160 |
Why?
|
Glycosylation | 5 | 2020 | 1126 | 0.160 |
Why?
|
Respiratory System | 1 | 2021 | 557 | 0.160 |
Why?
|
Complement System Proteins | 2 | 2018 | 795 | 0.160 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2021 | 1873 | 0.160 |
Why?
|
Mutant Proteins | 1 | 2020 | 500 | 0.160 |
Why?
|
Mutation | 7 | 2020 | 29786 | 0.160 |
Why?
|
Chemokine CCL3 | 2 | 2010 | 83 | 0.160 |
Why?
|
Patient Dropouts | 1 | 2020 | 421 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.160 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2019 | 323 | 0.160 |
Why?
|
Withholding Treatment | 2 | 2020 | 599 | 0.160 |
Why?
|
Flavivirus Infections | 1 | 2017 | 16 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 810 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1736 | 0.150 |
Why?
|
Immunophenotyping | 2 | 2014 | 1880 | 0.150 |
Why?
|
Trachea | 1 | 2023 | 1076 | 0.150 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2017 | 14 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6489 | 0.150 |
Why?
|
Binding Sites | 6 | 2021 | 6114 | 0.150 |
Why?
|
Up-Regulation | 2 | 2022 | 4217 | 0.150 |
Why?
|
Liposomes | 1 | 2021 | 759 | 0.150 |
Why?
|
Genes, MHC Class I | 2 | 1995 | 258 | 0.150 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2022 | 789 | 0.150 |
Why?
|
Interleukin-10 | 1 | 2023 | 1200 | 0.150 |
Why?
|
RNA Virus Infections | 1 | 2017 | 17 | 0.150 |
Why?
|
Syndrome | 1 | 2023 | 3251 | 0.150 |
Why?
|
Animals, Newborn | 3 | 2020 | 2726 | 0.150 |
Why?
|
Polysaccharides | 3 | 2023 | 1053 | 0.150 |
Why?
|
Genes, Bacterial | 1 | 2020 | 1079 | 0.140 |
Why?
|
Aspartate Aminotransferases | 1 | 2018 | 418 | 0.140 |
Why?
|
Autopsy | 1 | 2020 | 1020 | 0.140 |
Why?
|
Immunologic Techniques | 1 | 2017 | 218 | 0.140 |
Why?
|
Mannose | 1 | 2017 | 124 | 0.140 |
Why?
|
Ligands | 4 | 2011 | 3282 | 0.140 |
Why?
|
Platelet Activation | 1 | 2020 | 673 | 0.140 |
Why?
|
RNA Phages | 1 | 2016 | 3 | 0.140 |
Why?
|
Anti-HIV Agents | 4 | 2021 | 4256 | 0.140 |
Why?
|
Immunity | 2 | 2018 | 1012 | 0.140 |
Why?
|
Computational Biology | 5 | 2021 | 3521 | 0.140 |
Why?
|
Feces | 3 | 2017 | 1401 | 0.140 |
Why?
|
Cell Proliferation | 5 | 2017 | 10481 | 0.140 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2015 | 30 | 0.140 |
Why?
|
Systems Analysis | 1 | 2017 | 172 | 0.130 |
Why?
|
Sequence Analysis, DNA | 5 | 2017 | 4803 | 0.130 |
Why?
|
Antibodies, Bispecific | 1 | 2018 | 164 | 0.130 |
Why?
|
AIDS Serodiagnosis | 1 | 2017 | 184 | 0.130 |
Why?
|
Biocompatible Materials | 2 | 2021 | 1736 | 0.130 |
Why?
|
Dizziness | 1 | 2018 | 251 | 0.130 |
Why?
|
Puerto Rico | 1 | 2016 | 356 | 0.130 |
Why?
|
Genes, Viral | 2 | 2009 | 718 | 0.130 |
Why?
|
Aging | 2 | 2021 | 8664 | 0.130 |
Why?
|
Needles | 2 | 2019 | 449 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15540 | 0.130 |
Why?
|
Electrophoresis, Capillary | 1 | 2014 | 64 | 0.130 |
Why?
|
Injections, Subcutaneous | 3 | 2022 | 666 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2020 | 899 | 0.120 |
Why?
|
Listeria | 1 | 2014 | 27 | 0.120 |
Why?
|
Liver | 5 | 2015 | 7474 | 0.120 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3129 | 0.120 |
Why?
|
Antigen-Antibody Complex | 2 | 2015 | 517 | 0.120 |
Why?
|
Th17 Cells | 1 | 2020 | 766 | 0.120 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2020 | 810 | 0.120 |
Why?
|
Back Pain | 1 | 2018 | 545 | 0.120 |
Why?
|
Cerebrospinal Fluid | 1 | 2017 | 534 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2017 | 1147 | 0.120 |
Why?
|
Receptors, Virus | 2 | 2020 | 648 | 0.120 |
Why?
|
Retroviridae Proteins | 1 | 2013 | 98 | 0.120 |
Why?
|
Antigens, Heterophile | 1 | 2014 | 69 | 0.120 |
Why?
|
Vasculitis | 1 | 2018 | 519 | 0.120 |
Why?
|
Cohort Studies | 6 | 2022 | 40561 | 0.120 |
Why?
|
Weight Loss | 2 | 2022 | 2622 | 0.120 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 2013 | 65 | 0.120 |
Why?
|
Skin Absorption | 1 | 2013 | 94 | 0.120 |
Why?
|
Necrosis | 1 | 2018 | 1643 | 0.120 |
Why?
|
Flow Cytometry | 7 | 2019 | 5974 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 226 | 0.110 |
Why?
|
Nanocapsules | 1 | 2014 | 91 | 0.110 |
Why?
|
Cells, Cultured | 6 | 2020 | 19229 | 0.110 |
Why?
|
Polyomavirus | 1 | 1994 | 248 | 0.110 |
Why?
|
Maternal Exposure | 1 | 2020 | 961 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1117 | 0.110 |
Why?
|
Parvoviridae | 1 | 2012 | 7 | 0.110 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1799 | 0.110 |
Why?
|
Picornaviridae | 1 | 2012 | 23 | 0.110 |
Why?
|
Microinjections | 1 | 2013 | 327 | 0.110 |
Why?
|
Cysteine Endopeptidases | 1 | 1995 | 563 | 0.110 |
Why?
|
Chimera | 1 | 2014 | 485 | 0.110 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 482 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 655 | 0.110 |
Why?
|
Interferons | 1 | 2016 | 706 | 0.110 |
Why?
|
South Africa | 4 | 2022 | 1731 | 0.110 |
Why?
|
Multiple Organ Failure | 1 | 2015 | 390 | 0.100 |
Why?
|
Regression Analysis | 2 | 2020 | 6459 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1486 | 0.100 |
Why?
|
Administration, Intravaginal | 1 | 2012 | 150 | 0.100 |
Why?
|
Protein Stability | 1 | 2014 | 557 | 0.100 |
Why?
|
Transfection | 6 | 2016 | 5892 | 0.100 |
Why?
|
Microcephaly | 1 | 2016 | 432 | 0.100 |
Why?
|
Cyclohexanes | 1 | 2012 | 152 | 0.100 |
Why?
|
HIV Fusion Inhibitors | 1 | 2012 | 81 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 808 | 0.100 |
Why?
|
Models, Immunological | 2 | 2013 | 527 | 0.100 |
Why?
|
Antigens, CD | 3 | 2014 | 4026 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2018 | 1063 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 805 | 0.100 |
Why?
|
Aerosols | 1 | 2014 | 625 | 0.100 |
Why?
|
HEK293 Cells | 4 | 2021 | 4204 | 0.100 |
Why?
|
Diarrhea | 1 | 2018 | 1348 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 2 | 2020 | 1832 | 0.100 |
Why?
|
Models, Molecular | 6 | 2021 | 5456 | 0.100 |
Why?
|
Fatigue | 1 | 2018 | 1531 | 0.100 |
Why?
|
Species Specificity | 2 | 2012 | 2478 | 0.100 |
Why?
|
Alleles | 7 | 2021 | 6933 | 0.100 |
Why?
|
Goals | 1 | 2016 | 706 | 0.100 |
Why?
|
Toll-Like Receptor 9 | 1 | 2012 | 212 | 0.100 |
Why?
|
Electroporation | 2 | 2013 | 251 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2018 | 851 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9583 | 0.090 |
Why?
|
Melanoma | 2 | 2021 | 5510 | 0.090 |
Why?
|
Membrane Glycoproteins | 4 | 2014 | 3768 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 814 | 0.090 |
Why?
|
Carrier State | 1 | 2014 | 518 | 0.090 |
Why?
|
Virus Internalization | 2 | 2020 | 501 | 0.090 |
Why?
|
HIV Seronegativity | 1 | 2011 | 211 | 0.090 |
Why?
|
Spleen | 2 | 2015 | 2362 | 0.090 |
Why?
|
Tissue Donors | 1 | 2020 | 2240 | 0.090 |
Why?
|
Apoptosis | 2 | 2018 | 9727 | 0.090 |
Why?
|
Comorbidity | 2 | 2022 | 10388 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.090 |
Why?
|
Poly I-C | 1 | 2010 | 115 | 0.090 |
Why?
|
Hemorrhage | 1 | 2002 | 3461 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2005 | 4149 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 968 | 0.090 |
Why?
|
HIV Protease | 1 | 2010 | 96 | 0.090 |
Why?
|
DNA, Recombinant | 2 | 2010 | 476 | 0.090 |
Why?
|
Gene Deletion | 2 | 2016 | 2751 | 0.090 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 996 | 0.090 |
Why?
|
Immunotherapy | 2 | 2004 | 4445 | 0.090 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2009 | 87 | 0.090 |
Why?
|
HLA-A Antigens | 3 | 2011 | 231 | 0.090 |
Why?
|
Recombinant Proteins | 4 | 2014 | 6622 | 0.090 |
Why?
|
Poxviridae | 2 | 2010 | 37 | 0.090 |
Why?
|
Gestational Age | 1 | 2018 | 3493 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2459 | 0.080 |
Why?
|
Flavivirus | 2 | 2020 | 20 | 0.080 |
Why?
|
Calcinosis | 1 | 2018 | 1499 | 0.080 |
Why?
|
Research Design | 2 | 2023 | 5987 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4751 | 0.080 |
Why?
|
HLA Antigens | 2 | 2010 | 1381 | 0.080 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 276 | 0.080 |
Why?
|
Blood | 1 | 2011 | 598 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2866 | 0.080 |
Why?
|
Ectromelia virus | 1 | 2008 | 5 | 0.080 |
Why?
|
Major Histocompatibility Complex | 2 | 2005 | 936 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3778 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3479 | 0.080 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2020 | 87 | 0.080 |
Why?
|
Macrophages | 2 | 2020 | 5655 | 0.080 |
Why?
|
Prospective Studies | 4 | 2021 | 53288 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2022 | 6538 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2618 | 0.080 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 551 | 0.080 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.080 |
Why?
|
Lipids | 2 | 2022 | 3305 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2007 | 0.080 |
Why?
|
Heterocyclic Compounds, 3-Ring | 2 | 2021 | 215 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.080 |
Why?
|
Chemokine CCL4 | 2 | 2004 | 128 | 0.080 |
Why?
|
Escherichia coli | 2 | 2019 | 4217 | 0.080 |
Why?
|
Age Factors | 2 | 2022 | 18370 | 0.080 |
Why?
|
Macrophage Inflammatory Proteins | 2 | 2004 | 122 | 0.080 |
Why?
|
Polymerase Chain Reaction | 7 | 2017 | 6171 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2109 | 0.080 |
Why?
|
Birds | 1 | 2008 | 163 | 0.080 |
Why?
|
Cattle | 2 | 2017 | 3922 | 0.080 |
Why?
|
Longitudinal Studies | 3 | 2018 | 13989 | 0.080 |
Why?
|
Research | 1 | 2016 | 1999 | 0.080 |
Why?
|
Virus Diseases | 2 | 2006 | 711 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2014 | 2715 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57776 | 0.080 |
Why?
|
Point Mutation | 3 | 2004 | 1623 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2013 | 1375 | 0.070 |
Why?
|
Hospitalization | 3 | 2022 | 10262 | 0.070 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 281 | 0.070 |
Why?
|
Microspheres | 2 | 2021 | 777 | 0.070 |
Why?
|
Biological Evolution | 2 | 2023 | 1076 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2088 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2596 | 0.070 |
Why?
|
Influenza, Human | 1 | 2017 | 1479 | 0.070 |
Why?
|
Triazoles | 1 | 2012 | 911 | 0.070 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2010 | 571 | 0.070 |
Why?
|
Drug Combinations | 2 | 2022 | 1959 | 0.070 |
Why?
|
Colon | 1 | 2014 | 1772 | 0.070 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.070 |
Why?
|
Glycoproteins | 1 | 2014 | 2263 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.070 |
Why?
|
Chemoprevention | 1 | 2008 | 319 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 1723 | 0.070 |
Why?
|
Bone Marrow | 1 | 2016 | 2948 | 0.070 |
Why?
|
Polymers | 1 | 2013 | 1621 | 0.070 |
Why?
|
Phenotype | 5 | 2017 | 16365 | 0.070 |
Why?
|
Signal Transduction | 4 | 2021 | 23403 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4462 | 0.070 |
Why?
|
Defective Viruses | 2 | 2019 | 112 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2008 | 435 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2114 | 0.060 |
Why?
|
HLA-B7 Antigen | 1 | 2004 | 48 | 0.060 |
Why?
|
Injections, Intradermal | 2 | 2016 | 117 | 0.060 |
Why?
|
Immunity, Active | 1 | 2004 | 60 | 0.060 |
Why?
|
Trichosporon | 1 | 2003 | 8 | 0.060 |
Why?
|
Molecular Probes | 1 | 2005 | 316 | 0.060 |
Why?
|
3T3 Cells | 1 | 2005 | 1101 | 0.060 |
Why?
|
Herpesvirus 4, Human | 2 | 2001 | 1041 | 0.060 |
Why?
|
DNA Replication | 1 | 2010 | 1399 | 0.060 |
Why?
|
Aged | 11 | 2022 | 163280 | 0.060 |
Why?
|
Intestines | 1 | 2012 | 1924 | 0.060 |
Why?
|
Acute Disease | 3 | 2021 | 7149 | 0.060 |
Why?
|
Measles virus | 1 | 2003 | 68 | 0.060 |
Why?
|
Viral Structural Proteins | 1 | 2003 | 103 | 0.060 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2020 | 474 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39050 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2020 | 21746 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2216 | 0.050 |
Why?
|
Histone Deacetylase 2 | 1 | 2022 | 74 | 0.050 |
Why?
|
COS Cells | 1 | 2004 | 1161 | 0.050 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 62 | 0.050 |
Why?
|
Computer Simulation | 2 | 2020 | 6196 | 0.050 |
Why?
|
Immune Sera | 1 | 2022 | 641 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25043 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2440 | 0.050 |
Why?
|
Binding, Competitive | 2 | 2020 | 1157 | 0.050 |
Why?
|
Chemotaxis | 1 | 2004 | 607 | 0.050 |
Why?
|
Sulfonic Acids | 1 | 2021 | 96 | 0.050 |
Why?
|
Saccharomycetales | 1 | 2021 | 67 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2021 | 59 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2022 | 128 | 0.050 |
Why?
|
Measles | 1 | 2003 | 168 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2009 | 2839 | 0.050 |
Why?
|
Phagocytosis | 2 | 2017 | 1539 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 173 | 0.050 |
Why?
|
Limit of Detection | 1 | 2021 | 265 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2012 | 0.050 |
Why?
|
Viral Matrix Proteins | 2 | 2018 | 186 | 0.050 |
Why?
|
Mycoses | 1 | 2003 | 376 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2017 | 3597 | 0.050 |
Why?
|
Disease Progression | 3 | 2022 | 13284 | 0.050 |
Why?
|
Transcription Factors | 2 | 2022 | 12208 | 0.050 |
Why?
|
Polyomavirus Infections | 1 | 2002 | 197 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 12072 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2020 | 365 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 569 | 0.040 |
Why?
|
United States | 4 | 2022 | 69872 | 0.040 |
Why?
|
Proteins | 2 | 2010 | 6103 | 0.040 |
Why?
|
Thailand | 1 | 2020 | 296 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 56 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 452 | 0.040 |
Why?
|
Surface Plasmon Resonance | 2 | 2012 | 274 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13102 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12745 | 0.040 |
Why?
|
Protein Conformation | 3 | 2021 | 4011 | 0.040 |
Why?
|
Stearic Acids | 1 | 2019 | 53 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2017 | 2011 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2008 | 4420 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3309 | 0.040 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2001 | 314 | 0.040 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2005 | 643 | 0.040 |
Why?
|
Antibody-Dependent Enhancement | 1 | 2018 | 16 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 572 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2000 | 573 | 0.040 |
Why?
|
Bioreactors | 1 | 2019 | 236 | 0.040 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 1996 | 248 | 0.040 |
Why?
|
Guillain-Barre Syndrome | 1 | 2019 | 120 | 0.040 |
Why?
|
Body Temperature | 1 | 2021 | 777 | 0.040 |
Why?
|
Amides | 1 | 2021 | 459 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2017 | 2540 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2018 | 229 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2018 | 352 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 413 | 0.040 |
Why?
|
Child | 4 | 2022 | 77709 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9648 | 0.040 |
Why?
|
Macaca nemestrina | 1 | 2017 | 23 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 281 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2006 | 1401 | 0.040 |
Why?
|
Body Weight | 1 | 2008 | 4669 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 1998 | 964 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 456 | 0.040 |
Why?
|
Infant | 2 | 2011 | 35136 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 1791 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2021 | 986 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2005 | 11366 | 0.040 |
Why?
|
Binding Sites, Antibody | 1 | 2017 | 349 | 0.040 |
Why?
|
Intestine, Small | 1 | 2023 | 1241 | 0.040 |
Why?
|
Solubility | 1 | 1998 | 1085 | 0.040 |
Why?
|
Africa, Eastern | 1 | 2016 | 71 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2017 | 254 | 0.030 |
Why?
|
Pyridones | 1 | 2021 | 712 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2001 | 986 | 0.030 |
Why?
|
Chromatography, Gel | 2 | 2012 | 668 | 0.030 |
Why?
|
Injections | 1 | 2019 | 840 | 0.030 |
Why?
|
Chickens | 1 | 2017 | 865 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 936 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13408 | 0.030 |
Why?
|
Peptide Library | 1 | 1997 | 349 | 0.030 |
Why?
|
Lectins | 1 | 2018 | 513 | 0.030 |
Why?
|
Cryoelectron Microscopy | 2 | 2009 | 571 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1072 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2002 | 1381 | 0.030 |
Why?
|
HIV Reverse Transcriptase | 1 | 1995 | 213 | 0.030 |
Why?
|
Geography | 1 | 2017 | 669 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2016 | 438 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1025 | 0.030 |
Why?
|
Orthopoxvirus | 1 | 2013 | 11 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2499 | 0.030 |
Why?
|
Simian virus 40 | 1 | 1994 | 295 | 0.030 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2013 | 40 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1085 | 0.030 |
Why?
|
Interferon Type I | 1 | 2017 | 542 | 0.030 |
Why?
|
Precipitin Tests | 1 | 1994 | 829 | 0.030 |
Why?
|
Metagenomics | 1 | 2017 | 428 | 0.030 |
Why?
|
Cross-Priming | 1 | 2013 | 82 | 0.030 |
Why?
|
Virus Cultivation | 1 | 2013 | 92 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 436 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 4186 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1995 | 1454 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 5867 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1475 | 0.030 |
Why?
|
Dogs | 1 | 2017 | 3912 | 0.030 |
Why?
|
Metagenome | 1 | 2016 | 418 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2021 | 2258 | 0.030 |
Why?
|
Ultracentrifugation | 1 | 2012 | 182 | 0.030 |
Why?
|
Molecular Weight | 1 | 2014 | 2255 | 0.030 |
Why?
|
Transaminases | 1 | 2012 | 199 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2024 | 3589 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2013 | 711 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
Rabbits | 1 | 2018 | 4894 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2012 | 393 | 0.020 |
Why?
|
Brain | 1 | 2018 | 26385 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 868 | 0.020 |
Why?
|
Allergy and Immunology | 1 | 2012 | 169 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2014 | 1105 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9734 | 0.020 |
Why?
|
Lymphocyte Count | 2 | 2004 | 793 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2488 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2013 | 1341 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1420 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2004 | 7880 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 936 | 0.020 |
Why?
|
Fowlpox virus | 1 | 2009 | 20 | 0.020 |
Why?
|
Cowpox virus | 1 | 2008 | 1 | 0.020 |
Why?
|
Encephalitis Virus, Venezuelan Equine | 1 | 2008 | 5 | 0.020 |
Why?
|
Comet Assay | 1 | 2008 | 71 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6756 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3689 | 0.020 |
Why?
|
DNA | 2 | 2019 | 7301 | 0.020 |
Why?
|
Mycobacterium smegmatis | 1 | 2008 | 122 | 0.020 |
Why?
|
Bioterrorism | 1 | 2008 | 143 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14722 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1170 | 0.020 |
Why?
|
Adenovirus E4 Proteins | 1 | 2006 | 7 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4740 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4931 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.020 |
Why?
|
Adenovirus E1 Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
Retroviruses, Simian | 1 | 2005 | 12 | 0.020 |
Why?
|
Adenovirus E3 Proteins | 1 | 2005 | 7 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2006 | 562 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2009 | 1202 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1009 | 0.020 |
Why?
|
Diamines | 1 | 2005 | 59 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3582 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 627 | 0.020 |
Why?
|
Risk Factors | 2 | 2022 | 72290 | 0.020 |
Why?
|
Antigens, Nuclear | 1 | 2005 | 192 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2005 | 211 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2005 | 248 | 0.020 |
Why?
|
Vimentin | 1 | 2005 | 261 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1995 | 4328 | 0.020 |
Why?
|
Societies, Medical | 1 | 2016 | 3743 | 0.020 |
Why?
|
India | 1 | 2010 | 2197 | 0.010 |
Why?
|
Child, Preschool | 1 | 2006 | 41006 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 12720 | 0.010 |
Why?
|
Restriction Mapping | 1 | 2004 | 878 | 0.010 |
Why?
|
Culture Media | 1 | 2005 | 908 | 0.010 |
Why?
|
History, 20th Century | 1 | 2011 | 2740 | 0.010 |
Why?
|
Herpesvirus 8, Human | 1 | 2005 | 258 | 0.010 |
Why?
|
Haplorhini | 1 | 2003 | 552 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12951 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 2003 | 290 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9959 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5751 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3846 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 1941 | 0.010 |
Why?
|
Organ Specificity | 1 | 2006 | 2008 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1586 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2004 | 675 | 0.010 |
Why?
|
Hepatocytes | 1 | 2008 | 1211 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11483 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2010 | 1861 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25625 | 0.010 |
Why?
|
Quinolines | 1 | 2005 | 732 | 0.010 |
Why?
|
Warfarin | 1 | 2008 | 1496 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4364 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9239 | 0.010 |
Why?
|
California | 1 | 2003 | 1402 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1998 | 329 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1997 | 6314 | 0.010 |
Why?
|
Leukemia, Basophilic, Acute | 1 | 1997 | 15 | 0.010 |
Why?
|
Cell Degranulation | 1 | 1997 | 287 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15165 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5102 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 5021 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4042 | 0.010 |
Why?
|
Coloring Agents | 1 | 1996 | 566 | 0.010 |
Why?
|
DNA Probes | 1 | 1995 | 560 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2003 | 1772 | 0.010 |
Why?
|
Burkitt Lymphoma | 1 | 1995 | 327 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2006 | 3848 | 0.010 |
Why?
|
Kenya | 1 | 1995 | 685 | 0.010 |
Why?
|
Exons | 1 | 1995 | 2437 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12959 | 0.000 |
Why?
|
Gene Frequency | 1 | 1995 | 3588 | 0.000 |
Why?
|
Rats | 1 | 1997 | 24260 | 0.000 |
Why?
|